Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
图: 1 / 1
Torasemide, also known as torsemide, is a loop diuretic primarily used for the treatment of congestive heart failure and arterial hypertension. It functions by inhibiting the Na+/K+/2Cl- cotransporter in the thick ascending limb of the loop of Henle, leading to increased excretion of sodium, chloride, and water. Torasemide has a higher bioavailability (>80%) and a longer elimination half-life (3 to 4 hours) compared to furosemide, making it effective for long-term management of fluid overload conditions. The gene location and structure of torasemide are not directly applicable as it is a synthetic compound rather than a biologically derived biosimilar. However, its pharmacokinetics and pharmacodynamics have been extensively studied, showing a sigmoid E(max) model for its natriuretic rate versus excretion rate. Synonyms for torasemide include torsemide, Demadex, and others. It is important to note that torasemide has been tested negative in genotoxicity assays but was weakly carcinogenic to female rats in some studies.
仅用于科研。不用于诊断过程。未经明确授权不得转售。